Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Minneapolis, Minnesota
- Most recent report
- 8-K, filed Oct 8, 2026
- Filings on record
- 356 filings
- On EDGAR
- CIK 1771706
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 26
News 8 of 95
Prospectuses and Registrations 8 of 40
- S-4 Registration statement for a merger or exchange Oct 9, 2026
- S-3 Shelf registration statement Apr 23, 2026
- 424B3 Prospectus supplement for an offering Dec 19, 2025
- S-3 Shelf registration statement Dec 9, 2025
- 424B3 Prospectus supplement for an offering Oct 28, 2025
- S-8 Registration statement for an employee plan Aug 18, 2025
- 424B3 Prospectus supplement for an offering Jul 24, 2025
- S-3 Shelf registration statement Jul 15, 2025
Proxies 8 of 13
- DEFA14A Extra proxy material Apr 16, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2026
- PRE 14A Preliminary proxy statement Apr 6, 2026
- DEFA14A Extra proxy material May 9, 2025
- DEF 14A Proxy statement for a shareholder vote May 9, 2025
- DEFA14A Extra proxy material May 10, 2024
- DEF 14A Proxy statement for a shareholder vote May 10, 2024
- DEFA14A Extra proxy material Apr 17, 2024
Ownership 8 of 119
- 3 Insider reported their initial holding Jun 8, 2026
- 4 Insider reported a trade May 19, 2026
- 4 Insider reported a trade May 19, 2026
- 4 Insider reported a trade May 19, 2026
- 4 Insider reported a trade May 19, 2026
- 4 Insider reported a trade May 19, 2026
- 3 Insider reported their initial holding Apr 7, 2026
- 4 Insider reported a trade Dec 30, 2025
Other 8 of 63
Everything here comes from Vireo Growth Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.